Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemotherapy and radiation as the new standard for treating patients with pure or mixed anaplastic oligodendroglioma harboring the 1p/19q codeletion. For metastatic disease, increasing evidence supports the efficacy of stereotactic radiosurgery in treating patients with multiple metastatic lesions but low overall tumor volume. These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus. This version includes expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastomas, supratentorial primitive neuroectodermal tumors, and brain metastases. The full online version, available at NCCN. org, contains recommendations on additional subtypes.

  • 1.

    SiegelRNaishadhamDJemalA. Cancer statistics, 2013. CA Cancer J Clin2013;63:1130.

  • 2.

    MaherEAMcKeeAC. Neoplasms of the central nervous system. In: SkarinATCanellosGP eds. Atlas of Diagnostic Oncology. 3rd ed.London, United Kingdom: Elsevier Science Ltd; 2003.

    • Search Google Scholar
    • Export Citation
  • 3.

    PatchellRA. The management of brain metastases. Cancer Treat Rev2003;29:533540.

  • 4.

    SawayaRHammoudMSchoppaD. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery1998;42:10441055.

    • Search Google Scholar
    • Export Citation
  • 5.

    LouisDNOhgakiHWiestlerOD. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol2007;114:97109.

  • 6.

    PignattiFvan den BentMCurranD. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol2002;20:20762084.

    • Search Google Scholar
    • Export Citation
  • 7.

    DanielsTBBrownPDFeltenSJ. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys2011;81:218224.

    • Search Google Scholar
    • Export Citation
  • 8.

    ChangEFPottsMBKelesGE. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg2008;108:227235.

    • Search Google Scholar
    • Export Citation
  • 9.

    PiepmeierJChristopherSSpencerD. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery1996;38:872878; discussion 878-879.

    • Search Google Scholar
    • Export Citation
  • 10.

    AfraDOsztieESiposLVitanovicsD. Preoperative history and postoperative survival of supratentorial low-grade astrocytomas. Br J Neurosurg1999;13:299305.

    • Search Google Scholar
    • Export Citation
  • 11.

    CairncrossJGUekiKZlatescuMC. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst1998;90:14731479.

    • Search Google Scholar
    • Export Citation
  • 12.

    CBTRUS: Statistical report: Primary Brain Tumors in the United States 1995-1999. Chicago: Central Brain Tumor Registry of the United States; 2002.

    • Search Google Scholar
    • Export Citation
  • 13.

    LangFFGilbertMR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol2006;24:12361245.

  • 14.

    LoSSChoKHHallWA. Does the extent of surgery have an impact on the survival of patients who receive postoperative radiation therapy for supratentorial low-grade gliomas?Int J Cancer2001;96(Suppl):7178.

    • Search Google Scholar
    • Export Citation
  • 15.

    PhilipponJHClemenceauSHFauchonFHFoncinJF. Supratentorial low-grade astrocytomas in adults. Neurosurgery1993;32:554559.

  • 16.

    SoffiettiRChioAGiordanaMT. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery1989;24:686692.

    • Search Google Scholar
    • Export Citation
  • 17.

    SmithJSChangEFLambornKR. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol2008;26:13381345.

    • Search Google Scholar
    • Export Citation
  • 18.

    ShawEGDaumas-DuportCScheithauerBW. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg1989;70:853861.

    • Search Google Scholar
    • Export Citation
  • 19.

    KilicTOzdumanKElmaciI. Effect of surgery on tumor progression and malignant degeneration in hemispheric diffuse low-grade astrocytomas. J Clin Neurosci2002;9:549552.

    • Search Google Scholar
    • Export Citation
  • 20.

    McGirtMJChaichanaKLAttenelloFJ. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery2008;63:700707; author reply 707-708.

    • Search Google Scholar
    • Export Citation
  • 21.

    ChaichanaKLMcGirtMJLaterraJ. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg2010;112:1017.

    • Search Google Scholar
    • Export Citation
  • 22.

    BergerMSDeliganisAVDobbinsJKelesGE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer1994;74:17841791.

    • Search Google Scholar
    • Export Citation
  • 23.

    KarimABAfraDCornuP. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys2002;52:316324.

    • Search Google Scholar
    • Export Citation
  • 24.

    van den BentMJAfraDde WitteO. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet2005;366:985990.

    • Search Google Scholar
    • Export Citation
  • 25.

    ShawEGTatterSBLesserGJ. Current controversies in the radiotherapeutic management of adult low-grade glioma. Semin Oncol2004;31:653658.

    • Search Google Scholar
    • Export Citation
  • 26.

    ShawEGWisoffJH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol2003;5:153160.

  • 27.

    KarimABMaatBHatlevollR. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat Oncol Biol Phys1996;36:549556.

    • Search Google Scholar
    • Export Citation
  • 28.

    ShawEArusellRScheithauerB. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol2002;20:22672276.

    • Search Google Scholar
    • Export Citation
  • 29.

    RobergeDSouhamiLOlivierA. Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: long-term follow-up. Technol Cancer Res Treat2006;5:18.

    • Search Google Scholar
    • Export Citation
  • 30.

    QuinnJAReardonDAFriedmanAH. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol2003;21:646651.

    • Search Google Scholar
    • Export Citation
  • 31.

    KesariSSchiffDDrappatzJ. Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res2009;15:330337.

    • Search Google Scholar
    • Export Citation
  • 32.

    PouratianNGascoJShermanJH. Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. J Neurooncol2007;82:281288.

    • Search Google Scholar
    • Export Citation
  • 33.

    ShawEGBerkeyBCoonsSW. Initial report of Radiation Therapy Oncology Group (RTOG) 9802: prospective studies in adult low-grade glioma (LGG) [abstract]. J Clin Oncol2006;24(Suppl 18):Abstract 1500.

    • Search Google Scholar
    • Export Citation
  • 34.

    ShawEGWangMCoonsS. Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG) [abstract]. J Clin Oncol2008;26(Suppl 15):Abstract 2006.

    • Search Google Scholar
    • Export Citation
  • 35.

    PerryJRRizekPCashmanR. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the “rescue” approach. Cancer2008;113:21522157.

    • Search Google Scholar
    • Export Citation
  • 36.

    MassiminoMSpreaficoFRivaD. A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol2010;100:6571.

    • Search Google Scholar
    • Export Citation
  • 37.

    MoghrabiAFriedmanHSAshleyDM. Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas. Neurosurg Focus1998;4:e3.

  • 38.

    BrandesAABassoUVastolaF. Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study. Ann Oncol2003;14:17271731.

    • Search Google Scholar
    • Export Citation
  • 39.

    Hoang-XuanKCapelleLKujasM. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol2004;22:31333138.

    • Search Google Scholar
    • Export Citation
  • 40.

    KaloshiGBenouaich-AmielADiakiteF. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology2007;68:18311836.

    • Search Google Scholar
    • Export Citation
  • 41.

    BucknerJCGesmeDJrO’FallonJR. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol2003;21:251255.

    • Search Google Scholar
    • Export Citation
  • 42.

    CairncrossGMacdonaldDLudwinS. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol1994;12:20132021.

    • Search Google Scholar
    • Export Citation
  • 43.

    InoYBetenskyRAZlatescuMC. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res2001;7:839845.

    • Search Google Scholar
    • Export Citation
  • 44.

    van den BentMChinotOLCairncrossJG. Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro Oncol2003;5:128138.

    • Search Google Scholar
    • Export Citation
  • 45.

    HouillierCWangXKaloshiG. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology2010;75:15601566.

    • Search Google Scholar
    • Export Citation
  • 46.

    ShawEGBerkeyBCoonsSW. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial. J Neurosurg2008;109:835841.

    • Search Google Scholar
    • Export Citation
  • 47.

    LoSSHallWAChoKH. Radiation dose response for supratentorial low-grade glioma—institutional experience and literature review. J Neurol Sci2003;214:4348.

    • Search Google Scholar
    • Export Citation
  • 48.

    Central Brain Tumor Registry of the United States. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2006. Available at: http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf. Accessed January 17 2013.

    • Search Google Scholar
    • Export Citation
  • 49.

    CurranWJJrScottCBHortonJ. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst1993;85:704710.

    • Search Google Scholar
    • Export Citation
  • 50.

    CairncrossGBerkeyBShawE. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol2006;24:27072714.

    • Search Google Scholar
    • Export Citation
  • 51.

    LawsERParneyIFHuangW. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg2003;99:467473.

    • Search Google Scholar
    • Export Citation
  • 52.

    SimpsonJRHortonJScottC. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys1993;26:239244.

    • Search Google Scholar
    • Export Citation
  • 53.

    WoodJRGreenSBShapiroWR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol1988;6:338343.

    • Search Google Scholar
    • Export Citation
  • 54.

    LacroixMAbi-SaidDFourneyDR. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg2001;95:190198.

    • Search Google Scholar
    • Export Citation
  • 55.

    BarkerFG2ndChangSMGutinPH. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery1998;42:709720.

    • Search Google Scholar
    • Export Citation
  • 56.

    ParkJKHodgesTArkoL. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol2010;28:38383843.

  • 57.

    WalkerMDAlexanderEJrHuntWE. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg1978;49:333343.

    • Search Google Scholar
    • Export Citation
  • 58.

    KristiansenKHagenSKollevoldT. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer1981;47:649652.

    • Search Google Scholar
    • Export Citation
  • 59.

    Keime-GuibertFChinotOTaillandierL. Radiotherapy for glioblastoma in the elderly. N Engl J Med2007;356:15271535.

  • 60.

    RoaWBrasherPMBaumanG. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol2004;22:15831588.

    • Search Google Scholar
    • Export Citation
  • 61.

    MalmstromAGronbergBHMarosiC. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol201213:916926.

    • Search Google Scholar
    • Export Citation
  • 62.

    LaperriereNJLeungPMMcKenzieS. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys1998;41:10051011.

    • Search Google Scholar
    • Export Citation
  • 63.

    SouhamiLSeiferheldWBrachmanD. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys2004;60:853860.

    • Search Google Scholar
    • Export Citation
  • 64.

    NiederCAstnerSTMehtaMP. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol2008;31:300305.

    • Search Google Scholar
    • Export Citation
  • 65.

    CombsSEDebusJSchulz-ErtnerD. Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer2007;7:167.

  • 66.

    Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol2001;19:509518.

    • Search Google Scholar
    • Export Citation
  • 67.

    StewartLA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet2002;359:10111018.

    • Search Google Scholar
    • Export Citation
  • 68.

    FineHADearKBLoefflerJS. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer1993;71:25852597.

    • Search Google Scholar
    • Export Citation
  • 69.

    BremHPiantadosiSBurgerPC. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet1995;345:10081012.

    • Search Google Scholar
    • Export Citation
  • 70.

    ValtonenSTimonenUToivanenP. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery1997;41:4448; discussion 48-49.

    • Search Google Scholar
    • Export Citation
  • 71.

    WestphalMHiltDCBorteyE. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol2003;5:7988.

    • Search Google Scholar
    • Export Citation
  • 72.

    WestphalMRamZRiddleV. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien)2006;148:269275; discussion 275.

    • Search Google Scholar
    • Export Citation
  • 73.

    StuppRMasonWPvan den BentMJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med2005;352:987996.

  • 74.

    StuppRHegiMEMasonWP. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol2009;10:459466.

    • Search Google Scholar
    • Export Citation
  • 75.

    ClarkeJLIwamotoFMSulJ. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. J Clin Oncol2009;27:38613867.

    • Search Google Scholar
    • Export Citation
  • 76.

    GilbertMRWangMAldapeKD. RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM) [abstract]. J Clin Oncol2011;29(Suppl 15):Abstract 2006.

    • Search Google Scholar
    • Export Citation
  • 77.

    WickWHartmannCEngelC. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol2009;27:58745880.

    • Search Google Scholar
    • Export Citation
  • 78.

    WickWPlattenMMeisnerC. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol2012;13:707715.

    • Search Google Scholar
    • Export Citation
  • 79.

    MollemannMWolterMFelsbergJ. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. Int J Cancer2005;113:379385.

    • Search Google Scholar
    • Export Citation
  • 80.

    DixitSHingoraniMAchawalSScottI. The sequential use of carmustine wafers (Gliadel(R)) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. Br J Neurosurg2011;25:459469.

    • Search Google Scholar
    • Export Citation
  • 81.

    McGirtMJThanKDWeingartJD. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg2009;110:583588.

    • Search Google Scholar
    • Export Citation
  • 82.

    SalvatiMD’EliaAFratiA. Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis. J Neurosurg Sci2011;55:16.

    • Search Google Scholar
    • Export Citation
  • 83.

    BrandesAAVastolaFBassoU. A prospective study on glioblastoma in the elderly. Cancer2003;97:657662.

  • 84.

    MinnitiGDe SanctisVMuniR. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol2008;88:97103.

    • Search Google Scholar
    • Export Citation
  • 85.

    GlantzMChamberlainMLiuQ. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer2003;97:22622266.

    • Search Google Scholar
    • Export Citation
  • 86.

    CairncrossGWangMShawE. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol2013;31:337343.

    • Search Google Scholar
    • Export Citation
  • 87.

    van den BentMJBrandesAATaphoornMJ. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC Brain Tumor Group Study 26951. J Clin Oncol2013;31:344350.

    • Search Google Scholar
    • Export Citation
  • 88.

    PerryJRBelangerKMasonWP. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Oncol2010;28:20512057.

    • Search Google Scholar
    • Export Citation
  • 89.

    YungWKPradosMDYaya-TurR. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol1999;17:27622771.

    • Search Google Scholar
    • Export Citation
  • 90.

    WickWPuduvalliVKChamberlainMC. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol2010;28:11681174.

    • Search Google Scholar
    • Export Citation
  • 91.

    TriebelsVHTaphoornMJBrandesAA. Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas. Neurology2004;63:904906.

  • 92.

    ChamberlainMCTsao-WeiDD. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. Cancer2004;100:12131220.

    • Search Google Scholar
    • Export Citation
  • 93.

    ChamberlainMCTsao-WeiDDGroshenS. Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma. Cancer2006;106:172179.

    • Search Google Scholar
    • Export Citation
  • 94.

    ChamberlainMCWei-TsaoDDBlumenthalDTGlantzMJ. Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma. Cancer2008;112:20382045.

    • Search Google Scholar
    • Export Citation
  • 95.

    FultonDUrtasunRForsythP. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neurooncol1996;27:149155.

    • Search Google Scholar
    • Export Citation
  • 96.

    FriedmanHSPradosMDWenPY. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol2009;27:47334740.

    • Search Google Scholar
    • Export Citation
  • 97.

    VredenburghJJDesjardinsAHerndonJE2nd. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol2007;25:47224729.

    • Search Google Scholar
    • Export Citation
  • 98.

    KreislTNKimLMooreK. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol2009;27:740745.

    • Search Google Scholar
    • Export Citation
  • 99.

    ChamberlainMCJohnstonS. Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma. Cancer2009;115:17341743.

  • 100.

    ChamberlainMCJohnstonS. Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma. J Neurooncol2009;91:359367.

    • Search Google Scholar
    • Export Citation
  • 101.

    NordenADYoungGSSetayeshK. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology2008;70:779787.

    • Search Google Scholar
    • Export Citation
  • 102.

    SoffiettiRRudaRTrevisanE. Phase II study of bevacizumab and nitrosourea in patients with recurrent malignant glioma: a multicenter Italian study [abstract]. J Clin Oncol2009;27(Suppl 15S):Abstract 2012.

    • Search Google Scholar
    • Export Citation
  • 103.

    TaillibertSVincentLAGrangerB. Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Neurology2009;72:16011606.

  • 104.

    VredenburghJJDesjardinsAHerndonJE2nd. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res2007;13:12531259.

    • Search Google Scholar
    • Export Citation
  • 105.

    StuppRWongETKannerAA. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer2012;48:21922202.

    • Search Google Scholar
    • Export Citation
  • 106.

    YovinoSGrossmanSA. Treatment of glioblastoma in “elderly” patients. Curr Treat Options Oncol2011;12:253262.

  • 107.

    TsienCGalbanCJChenevertTL. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol2010;28:22932299.

    • Search Google Scholar
    • Export Citation
  • 108.

    FinkJBornDChamberlainMC. Pseudoprogression: relevance with respect to treatment of high-grade gliomas. Curr Treat Options Oncol2011;12:240252.

    • Search Google Scholar
    • Export Citation
  • 109.

    SurawiczTSMcCarthyBJKupelianV. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol1999;1:1425.

    • Search Google Scholar
    • Export Citation
  • 110.

    KunschnerLJKutteschJHessKYungWK. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol2001;3:167173.

    • Search Google Scholar
    • Export Citation
  • 111.

    PadovaniLSunyachMPPerolD. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys2007;68:433440.

    • Search Google Scholar
    • Export Citation
  • 112.

    CarrieCLassetCAlapetiteC. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer1994;74:23522360.

    • Search Google Scholar
    • Export Citation
  • 113.

    ChanAWTarbellNJBlackPM. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery2000;47:623631.

  • 114.

    FrostPJLaperriereNJWongCS. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys1995;32:951957.

  • 115.

    ChargariCFeuvretLLevyA. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse. Br J Neurosurg2010;24:460467.

    • Search Google Scholar
    • Export Citation
  • 116.

    DouglasJGBarkerJLEllenbogenRGGeyerJR. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Int J Radiat Oncol Biol Phys2004;58:11611164.

    • Search Google Scholar
    • Export Citation
  • 117.

    MerchantTEKunLEKrasinMJ. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys2008;70:782787.

    • Search Google Scholar
    • Export Citation
  • 118.

    DeutschMThomasPRKrischerJ. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children’s Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg1996;24:167176.

    • Search Google Scholar
    • Export Citation
  • 119.

    GermanwalaAVMaiJCTomyczND. Boost Gamma Knife surgery during multimodality management of adult medulloblastoma. J Neurosurg2008;108:204209.

    • Search Google Scholar
    • Export Citation
  • 120.

    RiffaudLSaikaliSLerayE. Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg2009;111:478487.

  • 121.

    HerrlingerUSteinbrecherARiegerJ. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol2005;252:291299.

    • Search Google Scholar
    • Export Citation
  • 122.

    PackerRJGajjarAVezinaG. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol2006;24:42024208.

    • Search Google Scholar
    • Export Citation
  • 123.

    AshleyDMMeierLKerbyT. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol1996;14:19221927.

  • 124.

    ChamberlainMCKormanikPA. Chronic oral VP-16 for recurrent medulloblastoma. Pediatr Neurol1997;17:230234.

  • 125.

    DunkelIJGardnerSLGarvinJHJr. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neuro Oncol2010;12:297303.

    • Search Google Scholar
    • Export Citation
  • 126.

    NicholsonHSKretschmarCSKrailoM. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children’s Oncology Group. Cancer2007;110:15421550.

    • Search Google Scholar
    • Export Citation
  • 127.

    GillPLitzowMBucknerJ. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer2008;112:18051811.

    • Search Google Scholar
    • Export Citation
  • 128.

    CohenMEDuffnerP eds. Brain Tumors in Children2nd ed.New York, NY: McGraw-Hill; 1994.

  • 129.

    ChangCHHousepianEMHerbertCJr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology1969;93:13511359.

    • Search Google Scholar
    • Export Citation
  • 130.

    BrandesAAFranceschiETosoniA. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol2009;71:165179.

    • Search Google Scholar
    • Export Citation
  • 131.

    Barnholtz-SloanJSSloanAEDavisFG. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol2004;22:28652872.

    • Search Google Scholar
    • Export Citation
  • 132.

    SchoutenLJRuttenJHuveneersHATwijnstraA. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer2002;94:26982705.

    • Search Google Scholar
    • Export Citation
  • 133.

    LinNUBellonJRWinerEP. CNS metastases in breast cancer. J Clin Oncol2004;22:36083617.

  • 134.

    EichlerAFLoefflerJS. Multidisciplinary management of brain metastases. Oncologist2007;12:884898.

  • 135.

    BarkerFG2nd. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer2004;100:9991007.

    • Search Google Scholar
    • Export Citation
  • 136.

    PatchellRATibbsPARegineWF. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA1998;280:14851489.

    • Search Google Scholar
    • Export Citation
  • 137.

    PaekSHAuduPBSperlingMR. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery2005;56:10211034.

    • Search Google Scholar
    • Export Citation
  • 138.

    StarkAMTscheslogHBuhlR. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev2005;28:115119.

    • Search Google Scholar
    • Export Citation
  • 139.

    SuhJH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med2010;362:11191127.

  • 140.

    BanfillKEBownesPJSt ClairSE. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival. Br J Neurosurg2012;26:674678.

    • Search Google Scholar
    • Export Citation
  • 141.

    BhatnagarAKFlickingerJCKondziolkaDLunsfordLD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys2006;64:898903.

    • Search Google Scholar
    • Export Citation
  • 142.

    KasedNBinderDKMcDermottMW. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys2009;75:11321140.

    • Search Google Scholar
    • Export Citation
  • 143.

    KarlssonBHanssensPWolffR. Thirty years’ experience with Gamma Knife surgery for metastases to the brain. J Neurosurg2009;111:449457.

    • Search Google Scholar
    • Export Citation
  • 144.

    HunterGKSuhJHReutherAM. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys2012;83:13941398.

    • Search Google Scholar
    • Export Citation
  • 145.

    AoyamaHShiratoHTagoM. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA2006;295:24832491.

    • Search Google Scholar
    • Export Citation
  • 146.

    ChangELWefelJSHessKR. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol2009;10:10371044.

    • Search Google Scholar
    • Export Citation
  • 147.

    KocherMSoffiettiRAbaciogluU. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol2011;29:134141.

    • Search Google Scholar
    • Export Citation
  • 148.

    TsaoMXuWSahgalA. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer2012;118:24862493.

    • Search Google Scholar
    • Export Citation
  • 149.

    O’NeillBPIturriaNJLinkMJ. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys2003;55:11691176.

    • Search Google Scholar
    • Export Citation
  • 150.

    RadesDKueterJDVeningaT. Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis. Eur J Cancer2009;45:400404.

    • Search Google Scholar
    • Export Citation
  • 151.

    SchogglAKitzKReddyM. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien)2000;142:621626.

    • Search Google Scholar
    • Export Citation
  • 152.

    MuacevicAWowraBSiefertA. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol2008;87:299307.

    • Search Google Scholar
    • Export Citation
  • 153.

    AkyurekSChangELMahajanA. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am J Clin Oncol2007;30:310314.

    • Search Google Scholar
    • Export Citation
  • 154.

    LoefflerJSKooyHMWenPY. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol1990;8:576582.

  • 155.

    NoelGMedioniJValeryCA. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer2003;41:333343.

    • Search Google Scholar
    • Export Citation
  • 156.

    NoelGProudhomMAValeryCA. Radiosurgery for reirradiation of brain metastasis: results in 54 patients. Radiother Oncol2001;60:6167.

  • 157.

    SheehanJKondziolkaDFlickingerJLunsfordLD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg2005;102(Suppl):247254.

    • Search Google Scholar
    • Export Citation
  • 158.

    PatchellRATibbsPAWalshJW. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med1990;322:494500.

    • Search Google Scholar
    • Export Citation
  • 159.

    VechtCJHaaxma-ReicheHNoordijkEM. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?Ann Neurol1993;33:583590.

    • Search Google Scholar
    • Export Citation
  • 160.

    MintzAHKestleJRathboneMP. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer1996;78:14701476.

    • Search Google Scholar
    • Export Citation
  • 161.

    AndrewsDWScottCBSperdutoPW. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet2004;363:16651672.

    • Search Google Scholar
    • Export Citation
  • 162.

    KondziolkaDPatelALunsfordLD. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys1999;45:427434.

    • Search Google Scholar
    • Export Citation
  • 163.

    CooperJSSteinfeldADLerchIA. Cerebral metastases: value of reirradiation in selected patients. Radiology1990;174:883885.

  • 164.

    SadikovEBezjakAYiQL. Value of whole brain reirradiation for brain metastases—single centre experience. Clin Oncol (R Coll Radiol)2007;19:532538.

    • Search Google Scholar
    • Export Citation
  • 165.

    WongWWSchildSESawyerTEShawEG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys1996;34:585590.

    • Search Google Scholar
    • Export Citation
  • 166.

    GuerrieriMWongKRyanG. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer2004;46:107111.

    • Search Google Scholar
    • Export Citation
  • 167.

    VergerEGilMYayaR. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys2005;61:185191.

    • Search Google Scholar
    • Export Citation
  • 168.

    AntonadouDParaskevaidisMSarrisG. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol2002;20:36443650.

    • Search Google Scholar
    • Export Citation
  • 169.

    EwendMGBremSGilbertM. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin Cancer Res2007;13:36373641.

    • Search Google Scholar
    • Export Citation
  • 170.

    AgarwalaSSKirkwoodJMGoreM. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol2004;22:21012107.

    • Search Google Scholar
    • Export Citation
  • 171.

    KrownSENiedzwieckiDHwuWJ. Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102). Cancer2006;107:18831890.

    • Search Google Scholar
    • Export Citation
  • 172.

    LassmanABAbreyLEShahGD. Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol2006;78:255260.

    • Search Google Scholar
    • Export Citation
  • 173.

    CocconiGLotticiRBisagniG. Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest1990;8:327334.

    • Search Google Scholar
    • Export Citation
  • 174.

    FranciosiVCocconiGMichiaraM. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer1999;85:15991605.

    • Search Google Scholar
    • Export Citation
  • 175.

    RiveraEMeyersCGrovesM. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer2006;107:13481354.

    • Search Google Scholar
    • Export Citation
  • 176.

    MetroGFogliettaJRussilloM. Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. Ann Oncol2011;22:625630.

    • Search Google Scholar
    • Export Citation
  • 177.

    SutherlandSAshleySMilesD. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience. Br J Cancer2010;102:9951002.

    • Search Google Scholar
    • Export Citation
  • 178.

    HeddeJPNeuhausTSchullerH. A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors. Int J Radiat Oncol Biol Phys2007;68:839844.

    • Search Google Scholar
    • Export Citation
  • 179.

    NeuhausTKoYMullerRP. A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. Br J Cancer2009;100:291297.

    • Search Google Scholar
    • Export Citation
  • 180.

    LangFFChangELAbi-SaidD. Metastatic brain tumors. In: WinnH ed. Youman’s Neurological Surgery. 5th ed.Philadelphia, PA: Saunders; 2004:10771097.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 108 108 12
PDF Downloads 35 35 2
EPUB Downloads 0 0 0